Standards & Regulations

Nov 05, 2012
By BioPharm International Editors
USP revises labeling requirements for Heparin.
Sep 25, 2012
By BioPharm International Editors
The European Medicines Agency (EMA) has abolished its Cell-based Product Working Party (CPWP) and Gene Therapy Working Party (GTWP), with the aim of improving efficiencies and optimising the use of available expertise.
Sep 18, 2012
The European Generic Medicines Association (EGA) has raised concerns about the potential fees to be charged by the European Medicines Agency for pharmacovigilance activities
Sep 03, 2012
By BioPharm International Editors
The European Medicines Agency has launched a public consultation concerning its inventory of paediatric medicines with the aim of highlighting where further R&D efforts are required. The consultation is the first of its kind in this area.
native1_300x100
lorem ipsum